These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 28441015)
21. Fabrication of Reductive-Responsive Prodrug Nanoparticles with Superior Structural Stability by Polymerization-Induced Self-Assembly and Functional Nanoscopic Platform for Drug Delivery. Zhang WJ; Hong CY; Pan CY Biomacromolecules; 2016 Sep; 17(9):2992-9. PubMed ID: 27548375 [TBL] [Abstract][Full Text] [Related]
22. Tumor-targeting, pH-responsive, and stable unimolecular micelles as drug nanocarriers for targeted cancer therapy. Yang X; Grailer JJ; Pilla S; Steeber DA; Gong S Bioconjug Chem; 2010 Mar; 21(3):496-504. PubMed ID: 20163170 [TBL] [Abstract][Full Text] [Related]
23. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles. Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683 [TBL] [Abstract][Full Text] [Related]
24. Polymersome nanoreactors with tumor pH-triggered selective membrane permeability for prodrug delivery, activation, and combined oxidation-chemotherapy. Mukerabigwi JF; Yin W; Zha Z; Ke W; Wang Y; Chen W; Japir AAMM; Wang Y; Ge Z J Control Release; 2019 Jun; 303():209-222. PubMed ID: 31026547 [TBL] [Abstract][Full Text] [Related]
25. Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors. Fang T; Dong Y; Zhang X; Xie K; Lin L; Wang H Int J Pharm; 2016 Oct; 512(1):39-48. PubMed ID: 27544846 [TBL] [Abstract][Full Text] [Related]
26. Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies. Zhang H; Wang J; Mao W; Huang J; Wu X; Shen Y; Sui M J Control Release; 2013 Mar; 166(2):147-58. PubMed ID: 23266448 [TBL] [Abstract][Full Text] [Related]
27. Sub-100nm, long tumor retention SN-38-loaded photonic micelles for tri-modal cancer therapy. Yang X; Xue X; Luo Y; Lin TY; Zhang H; Lac D; Xiao K; He Y; Jia B; Lam KS; Li Y J Control Release; 2017 Sep; 261():297-306. PubMed ID: 28700898 [TBL] [Abstract][Full Text] [Related]
28. Hydroxyethyl starch conjugates for improving the stability, pharmacokinetic behavior and antitumor activity of 10-hydroxy camptothecin. Li G; Li Y; Tang Y; Zhang Y; Zhang Y; Yin T; Xu H; Cai C; Tang X Int J Pharm; 2014 Aug; 471(1-2):234-44. PubMed ID: 24861941 [TBL] [Abstract][Full Text] [Related]
29. Nanomicelle Based Peroral Delivery System for Enhanced Absorption and Sustained Release of 10-Hydrocamptothecin. Tian Y; Shi C; Zhang X; Sun Y; Wang J; Zhang Y; Yang J; Wang L; Wang L; Mao S J Biomed Nanotechnol; 2015 Feb; 11(2):262-73. PubMed ID: 26349302 [TBL] [Abstract][Full Text] [Related]
30. Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity. Liu Y; Piao H; Gao Y; Xu C; Tian Y; Wang L; Liu J; Tang B; Zou M; Cheng G Int J Nanomedicine; 2015; 10():2295-311. PubMed ID: 25848251 [TBL] [Abstract][Full Text] [Related]
31. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting. Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430 [TBL] [Abstract][Full Text] [Related]
32. Self-assembled micelles from an amphiphilic hyperbranched copolymer with polyphosphate arms for drug delivery. Liu J; Huang W; Pang Y; Zhu X; Zhou Y; Yan D Langmuir; 2010 Jul; 26(13):10585-92. PubMed ID: 20384307 [TBL] [Abstract][Full Text] [Related]
34. Smart nanorods for highly effective cancer theranostic applications. Yang Y; Zhang X; Yu C; Hao X; Jie J; Zhou M; Zhang X Adv Healthc Mater; 2014 Jun; 3(6):906-15. PubMed ID: 24376098 [TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory polymersomes of redox-responsive polyprodrug amphiphiles with inflammation-triggered indomethacin release characteristics. Tan J; Deng Z; Liu G; Hu J; Liu S Biomaterials; 2018 Sep; 178():608-619. PubMed ID: 29605185 [TBL] [Abstract][Full Text] [Related]
36. Lysine-mediated hydroxyethyl starch-10-hydroxy camptothecin micelles for the treatment of liver cancer. Li G; Zhao M; Zhao L Drug Deliv; 2020 Dec; 27(1):519-529. PubMed ID: 32228107 [TBL] [Abstract][Full Text] [Related]
37. Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid Tumors. Nguyen F; Guan P; Guerrero DT; Kolla V; Naraparaju K; Perry LM; Soberman D; Pressly BB; Alferiev IS; Chorny M; Brodeur GM Cancer Res; 2020 Oct; 80(19):4258-4265. PubMed ID: 32839252 [TBL] [Abstract][Full Text] [Related]
38. Biodegradable and biocompatible multi-arm star amphiphilic block copolymer as a carrier for hydrophobic drug delivery. Aryal S; Prabaharan M; Pilla S; Gong S Int J Biol Macromol; 2009 May; 44(4):346-52. PubMed ID: 19428465 [TBL] [Abstract][Full Text] [Related]
39. Novel polymeric micelles as enzyme-sensitive nuclear-targeted dual-functional drug delivery vehicles for enhanced 9-nitro-20(S)-camptothecin delivery and antitumor efficacy. Sun Y; Liang Y; Hao N; Fu X; He B; Han S; Cao J; Ma Q; Xu W; Sun Y Nanoscale; 2020 Mar; 12(9):5380-5396. PubMed ID: 32022069 [TBL] [Abstract][Full Text] [Related]
40. Hyperbranched polycarbonate-based multimolecular micelle with enhanced stability and loading efficiency. Su W; Luo XH; Wang HF; Li L; Feng J; Zhang XZ; Zhuo RX Macromol Rapid Commun; 2011 Feb; 32(4):390-6. PubMed ID: 21433189 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]